AdaptHealth Corp. (NASDAQ:AHCO) Receives $12.10 Consensus PT from Brokerages (2024)

Shares of AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report) have earned an average rating of “Hold” from the seven research firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $12.10.

Several research analysts recently commented on AHCO shares. Truist Financial boosted their target price on AdaptHealth from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. UBS Group boosted their target price on AdaptHealth from $9.00 to $13.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. Jefferies Financial Group cut AdaptHealth from a “buy” rating to a “hold” rating and lowered their target price for the stock from $14.50 to $8.00 in a research note on Monday, January 8th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $13.00 target price on shares of AdaptHealth in a research note on Monday, March 4th.

Get Our Latest Report on AHCO

AdaptHealth Trading Up 1.3 %

AHCO opened at $10.28 on Friday. AdaptHealth has a 12 month low of $6.37 and a 12 month high of $15.37. The stock has a market capitalization of $1.37 billion, a price-to-earnings ratio of -1.94, a PEG ratio of 0.68 and a beta of 1.01. The company has a debt-to-equity ratio of 1.44, a current ratio of 1.21 and a quick ratio of 1.00. The business has a fifty day moving average price of $8.10 and a 200 day moving average price of $8.28.

Insider Transactions at AdaptHealth

In other news, major shareholder James E. Flynn sold 182,607 shares of the business’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $11.02, for a total value of $2,012,329.14. Following the completion of the sale, the insider now directly owns 11,643,769 shares of the company’s stock, valued at approximately $128,314,334.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other AdaptHealth news, major shareholder James E. Flynn sold 52,487 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $10.93, for a total transaction of $573,682.91. Following the completion of the sale, the insider now directly owns 11,826,376 shares of the company’s stock, valued at approximately $129,262,289.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder James E. Flynn sold 182,607 shares of the company’s stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $11.02, for a total value of $2,012,329.14. Following the sale, the insider now directly owns 11,643,769 shares of the company’s stock, valued at $128,314,334.38. The disclosure for this sale can be found here. Insiders own 13.60% of the company’s stock.

Institutional Trading of AdaptHealth

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Commonwealth Equity Services LLC raised its stake in shares of AdaptHealth by 1.8% during the 3rd quarter. Commonwealth Equity Services LLC now owns 28,364 shares of the company’s stock worth $532,000 after buying an additional 491 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of AdaptHealth by 2.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 30,979 shares of the company’s stock worth $377,000 after buying an additional 887 shares in the last quarter. First Republic Investment Management Inc. raised its stake in shares of AdaptHealth by 3.8% during the 2nd quarter. First Republic Investment Management Inc. now owns 24,990 shares of the company’s stock worth $451,000 after buying an additional 924 shares in the last quarter. ProShare Advisors LLC raised its stake in shares of AdaptHealth by 9.2% during the 2nd quarter. ProShare Advisors LLC now owns 11,574 shares of the company’s stock worth $141,000 after buying an additional 978 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of AdaptHealth by 2.7% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 37,652 shares of the company’s stock worth $469,000 after buying an additional 984 shares in the last quarter. 82.67% of the stock is owned by hedge funds and other institutional investors.

AdaptHealth Company Profile

(Get Free Report

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Featured Articles

• Five stocks we like better than AdaptHealth
• What is a Low P/E Ratio and What Does it Tell Investors?
• MarketBeat Week in Review – 3/11 – 3/15
• How to Invest in Tech Stocksand Top Tech Stocks to Consider
• Why Dollar General and Dollar Tree Are Similar Yet Different
• The 3 Best Blue-Chip Stocks to Buy Now
• Jabil Stock Implodes: Market Manufactures Entry for New Money

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.